Skip to main content
. 2013 Jun 18;13:293. doi: 10.1186/1471-2407-13-293

Figure 3.

Figure 3

Kaplan-Meier survival curves for NPC patients without distant metastases.BAX mRNA expression status possesses a favorable prognostic value in these patients, as patients with BAX mRNA-positive nonmetastatic nasopharyngeal tumors have a significantly higher probability of DFS (P < 0.001) (A) and OS (P = 0.009) (B) anytime, in comparison with metastasis-free patients bearing BAX mRNA-negative tumors.